Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12012394 Alpha-synuclein ligands

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Paul T. Kotzbauer0

Xuyi Yue0

Dhruva D. Dhavale0

Zhude Tu0

Date of Patent

June 18, 2024

0

Patent Application Number

162776430

Date Filed

February 15, 2019

0

Patent Citations

US Patent 7485647 2-aminoquinoline derivatives

0

US Patent 8399674 Quinolines

0

US Patent 9303015 Heteroaryl linked quinolinyl modulators of RORγt

0

US Patent 9290463 Radiolabeled compounds and uses thereof

0

US Patent 9796718 6-(benzo[d]thiazol-5-yl)-n-(3,4-dimethoxyphenyl)imidazo[1,2-a]pyrazin-8-amine

0

US Patent 7084156 2-Aminoquinoline compounds

0

US Patent 7087758 Quinoline inhibitors of hyaki and hyak3 kinases

0

Patent Primary Examiner

0

CPC Code

0

0

0

Patent abstract

The present invention generally relates to various compounds that are useful as α-synuclein ligands. The invention further relates to methods of using these compounds and their radiolabeled analogs for the detection of synucleinopathies, including Parkinson's disease (PD).

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12012394 Alpha-synuclein ligands

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool